Publication: Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder
Issued Date
2007-01-01
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-33847002316
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.90, No.1 (2007), 179-181
Suggested Citation
Harirak Wanmuang, Juvady Leopairut, Chomsri Kositchaiwat, Winai Wananukul, Sukhum Bunyaratvej Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. Journal of the Medical Association of Thailand. Vol.90, No.1 (2007), 179-181. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/25047
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder
Other Contributor(s)
Abstract
Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.